These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 21619903

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.
    Ara MN, Matsuda T, Hyodo M, Sakurai Y, Hatakeyama H, Ohga N, Hida K, Harashima H.
    Biomaterials; 2014 Aug; 35(25):7110-20. PubMed ID: 24875764
    [Abstract] [Full Text] [Related]

  • 23. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.
    Abu Lila AS, Kizuki S, Doi Y, Suzuki T, Ishida T, Kiwada H.
    J Control Release; 2009 Jul 01; 137(1):8-14. PubMed ID: 19285528
    [Abstract] [Full Text] [Related]

  • 24. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery.
    Li W, Huang Z, MacKay JA, Grube S, Szoka FC.
    J Gene Med; 2005 Jan 01; 7(1):67-79. PubMed ID: 15515149
    [Abstract] [Full Text] [Related]

  • 25. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route.
    Hattori Y, Suzuki S, Kawakami S, Yamashita F, Hashida M.
    J Control Release; 2005 Nov 28; 108(2-3):484-95. PubMed ID: 16181701
    [Abstract] [Full Text] [Related]

  • 26. Efficient siRNA Delivery by Lipid Nanoparticles Modified with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting.
    Sakurai Y, Mizumura W, Murata M, Hada T, Yamamoto S, Ito K, Iwasaki K, Katoh T, Goto Y, Takagi A, Kohara M, Suga H, Harashima H.
    Mol Pharm; 2017 Oct 02; 14(10):3290-3298. PubMed ID: 28789523
    [Abstract] [Full Text] [Related]

  • 27. Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo.
    Hatakeyama H, Akita H, Maruyama K, Suhara T, Harashima H.
    Int J Pharm; 2004 Aug 20; 281(1-2):25-33. PubMed ID: 15288340
    [Abstract] [Full Text] [Related]

  • 28. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice.
    Merdan T, Kunath K, Petersen H, Bakowsky U, Voigt KH, Kopecek J, Kissel T.
    Bioconjug Chem; 2005 Aug 20; 16(4):785-92. PubMed ID: 16029019
    [Abstract] [Full Text] [Related]

  • 29. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
    Nakamura Y, Kogure K, Futaki S, Harashima H.
    J Control Release; 2007 Jun 22; 119(3):360-7. PubMed ID: 17478000
    [Abstract] [Full Text] [Related]

  • 30. Development of lipid particles targeted via sugar-lipid conjugates as novel nuclear gene delivery system.
    Masuda T, Akita H, Nishio T, Niikura K, Kogure K, Ijiro K, Harashima H.
    Biomaterials; 2008 Feb 22; 29(6):709-23. PubMed ID: 18001828
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
    Yamada Y, Hashida M, Harashima H.
    Biomaterials; 2015 Jun 22; 52():189-98. PubMed ID: 25818425
    [Abstract] [Full Text] [Related]

  • 33. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH, Lin YY, Hwang JJ, Wang HE, Tseng YL, Wang SJ, Liu RS, Lin WJ, Yang CS, Ting G.
    Anticancer Res; 2009 Jun 22; 29(6):2111-20. PubMed ID: 19528471
    [Abstract] [Full Text] [Related]

  • 34. Steric stabilization of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes mediates prolonged circulation and tumor targeting in mice.
    Verbaan FJ, Oussoren C, Snel CJ, Crommelin DJ, Hennink WE, Storm G.
    J Gene Med; 2004 Jan 22; 6(1):64-75. PubMed ID: 14716678
    [Abstract] [Full Text] [Related]

  • 35. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y, Machida Y, Honda M, Takeuchi N, Yoshiike Y, Ohno H, Onishi H.
    J Liposome Res; 2017 Dec 22; 27(4):264-273. PubMed ID: 27345333
    [Abstract] [Full Text] [Related]

  • 36. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption.
    Yamamoto S, Sakurai Y, Harashima H.
    Int J Pharm; 2018 Jan 30; 536(1):42-49. PubMed ID: 29126905
    [Abstract] [Full Text] [Related]

  • 37. Enhanced gene delivery using Bubble liposomes and ultrasound for folate-PEG liposomes.
    Omata D, Negishi Y, Hagiwara S, Yamamura S, Endo-Takahashi Y, Suzuki R, Maruyama K, Aramaki Y.
    J Drug Target; 2012 May 30; 20(4):355-63. PubMed ID: 22332850
    [Abstract] [Full Text] [Related]

  • 38. Decaarginine-PEG-liposome enhanced transfection efficiency and function of arginine length and PEG.
    Furuhata M, Izumisawa T, Kawakami H, Toma K, Hattori Y, Maitani Y.
    Int J Pharm; 2009 Apr 17; 371(1-2):40-6. PubMed ID: 19135138
    [Abstract] [Full Text] [Related]

  • 39. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions.
    Anwer K, Kao G, Proctor B, Rolland A, Sullivan S.
    J Drug Target; 2000 Apr 17; 8(2):125-35. PubMed ID: 10852344
    [Abstract] [Full Text] [Related]

  • 40. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N, Tong YW, Yang YY.
    Biomaterials; 2009 Jun 17; 30(17):3100-9. PubMed ID: 19342093
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.